{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:52Z","timestamp":1786975672768,"version":"build-2736575974"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Chronic total occlusion percutaneous coronary intervention (CTO-PCI) is not usually offered because of skepticism about long-term clinical benefits.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the association of successful CTO-PCI with quality of life by analyzing the relevant domains of the Seattle Angina Questionnaire (SAQ).<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed, EMBASE, Web of Science, Google Scholar, and Cochrane databases were searched to identify randomized trials and observational studies specifically addressing quality of life domains of SAQ from January 2010 to June 2022.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Studies included reporting SAQ metrics such as angina frequency, physical limitation, and quality of life, before and after CTO-PCI.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n The present study was performed according to the Cochrane Collaboration and Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements, in which fixed-effect or random-effect models with generic inverse-variance weighting depending on statistical homogeneity were applied. Data were extracted by 3 independent reviewers.<\/jats:p>\n <\/jats:sec>\n \n Outcomes and Measures<\/jats:title>\n The primary outcome was angina frequency; physical limitation and quality of life were assessed as secondary outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Seven prospective randomized or observational studies (2500 patients) were included, with a mean (SD) participant age of 61.2 (2.1) years. CTO-PCI was associated with significantly improved quality-of-life metrics during a mean (SD) follow-up of 14.8 (16.3) months. In patients with successful procedures, angina episodes became less frequent (mean [SD] difference for SAQ angina frequency of 12.9 [3.1] survey points [95% CI, 7.1-19.8 survey points]; standardized mean difference was 0.54 [95% CI, 0.21-0.92];\n P<\/jats:italic>\n \u2009=\u2009.002;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u200986.4%) and they experienced less physical activity limitation (mean [SD] difference for SAQ physical limitation of 9.7 [6.2] survey points [95% CI, 3.5-16.2 survey points]; standardized mean difference was 0.42 [95% CI, 0.24-0.55];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u200920.9%), and greater quality-of-life domain (mean [SD] difference for SAQ quality of life of 14.9 [3.5] survey points [95% CI, 7.7-22.5 survey points]; standardized mean difference was 0.41 [95% CI, 0.25-0.61];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001;\n I<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u200958.8%) compared with patients with optimal medical therapy or failed procedure. Furthermore, follow-up duration (point estimate, 0.03; 95% CI, 0.01-0.04;\n P<\/jats:italic>\n \u2009=\u2009.01) was associated with a significant decrease in angina frequency in meta-regression analysis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this systematic review and meta-analysis examining quality of life following CTO-PCI, successful procedures were associated with improved quality-of-life parameters compared with patients on optimal medical therapy or after failed CTO-PCI. These findings suggest support for using PCI to treat CTOs in symptomatic patients unresponsive to medical treatment.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.24522","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T11:41:26Z","timestamp":1689853286000},"page":"e2324522","source":"Crossref","is-referenced-by-count":29,"title":["Association of Successful Percutaneous Revascularization of Chronic Total Occlusions With Quality of Life"],"prefix":"10.1001","volume":"6","author":[{"given":"Selcuk","family":"Kucukseymen","sequence":"first","affiliation":[{"name":"Structural Interventional Cardiology, University Hospital Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Iannaccone","sequence":"additional","affiliation":[{"name":"Cardiology Department, San Giovanni Bosco Hospital, ASL Citt\u00e0 di Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Grantham","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saint Luke\u2019s Mid America Heart Institute, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sapontis","sequence":"additional","affiliation":[{"name":"Monash Heart, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Juricic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Ciardetti","sequence":"additional","affiliation":[{"name":"Structural Interventional Cardiology, University Hospital Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mattesini","sequence":"additional","affiliation":[{"name":"Structural Interventional Cardiology, University Hospital Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Stojkovic","sequence":"additional","affiliation":[{"name":"Clinic for Cardiology, University Clinical Center of Serbia, Belgrade, Serbia"},{"name":"School of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley H.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Schulich Heart Program, Division of Cardiology, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harindra C.","family":"Wijeysundera","sequence":"additional","affiliation":[{"name":"Schulich Heart Program, Division of Cardiology, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Werner","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I, Klinikum Darmstadt GmbH, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"D\u2019Ascenzo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medical Science, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Mario","sequence":"additional","affiliation":[{"name":"Structural Interventional Cardiology, University Hospital Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"issue":"4","key":"zoi230719r1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ccd.v84.4","article-title":"Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital.","volume":"84","author":"Jeroudi","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"zoi230719r2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.amjcard.2016.07.023","article-title":"Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion.","volume":"118","author":"Azzalini","year":"2016","journal-title":"Am J Cardiol"},{"issue":"11","key":"zoi230719r3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jacc.2011.12.007","article-title":"Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.","volume":"59","author":"Fefer","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"zoi230719r4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jcin.2009.02.008","article-title":"Chronic total occlusion angioplasty in the United States.","volume":"2","author":"Grantham","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"zoi230719r5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.119.039797","article-title":"Guiding principles for chronic total occlusion percutaneous coronary intervention.","volume":"140","author":"Brilakis","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"zoi230719r6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis.","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"issue":"2","key":"zoi230719r7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ccd.v100.2","article-title":"Second generation drug eluting stent: the longer, the better?","volume":"100","author":"Di Mario","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"14","key":"zoi230719r8","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion.","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"zoi230719r9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jcin.2018.04.017","article-title":"The IMPACTOR-CTO Trial.","volume":"11","author":"Obedinskiy","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"zoi230719r10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2016.07.744","article-title":"Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial.","volume":"68","author":"Henriques","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi230719r11","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi230719r12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"zoi230719r13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease.","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"zoi230719r14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease.","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"issue":"35","key":"zoi230719r15","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1093\/eurheartj\/ehv391","article-title":"Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview.","volume":"37","author":"Galassi","year":"2016","journal-title":"Eur Heart J"},{"issue":"22","key":"zoi230719r16","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.jcin.2018.08.021","article-title":"Chronic total occlusion revascularization and quality-of-life improvement across all levels of left ventricular function: many questions still unanswered.","volume":"11","author":"Guzman","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"zoi230719r17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.carrev.2020.10.006","article-title":"Association between revascularization and quality of life in patients with coronary chronic total occlusions: a systematic review.","volume":"25","author":"Abuzeid","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"issue":"9193","key":"zoi230719r18","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. quality of reporting of meta-analyses.","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"b2535","key":"zoi230719r19","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"15","key":"zoi230719r20","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"zoi230719r21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"zoi230719r22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4244\/EIJV9I10A197","article-title":"Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions.","volume":"9","author":"Wijeysundera","year":"2014","journal-title":"EuroIntervention"},{"issue":"1","key":"zoi230719r23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2011.04.023","article-title":"Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions.","volume":"161","author":"Borgia","year":"2012","journal-title":"Int J Cardiol"},{"issue":"3","key":"zoi230719r24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCOUTCOMES.108.825760","article-title":"Quantifying the early health status benefits of successful chronic total occlusion recanalization: results from the FlowCardia\u2019s Approach to Chronic Total Occlusion Recanalization (FACTOR) trial.","volume":"3","author":"Grantham","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"zoi230719r25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1536\/ihj.20-427","article-title":"Randomized controlled comparison of optimal medical therapy with percutaneous recanalization of chronic total occlusion (COMET-CTO).","volume":"62","author":"Juricic","year":"2021","journal-title":"Int Heart J"},{"issue":"15","key":"zoi230719r26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jcin.2017.05.065","article-title":"Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures).","volume":"10","author":"Sapontis","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"26","key":"zoi230719r27","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"zoi230719r30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.120.046754","article-title":"Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations.","volume":"143","author":"Ybarra","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"zoi230719r31","first-page":"44","article-title":"Angina severity, depression, and response to percutaneous revascularization in patients with chronic total occlusion of coronary arteries.","volume":"28","author":"Bruckel","year":"2016","journal-title":"J Invasive Cardiol"},{"issue":"5","key":"zoi230719r32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ccd.25736","article-title":"Treatment of the chronic total occlusion: a call to action for the interventional community.","volume":"85","author":"Carlino","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"zoi230719r33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/ehjqcco\/qcz015","article-title":"Anti-anginal medication titration among patients with residual angina 6-months after chronic total occlusion percutaneous coronary intervention: insights from OPEN CTO registry.","volume":"5","author":"Sheehy","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"45","key":"zoi230719r34","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1093\/eurheartj\/ehv450","article-title":"Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions.","volume":"36","author":"Tomasello","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi230719r35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcin.2014.10.010","article-title":"Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation.","volume":"8","author":"Jang","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"zoi230719r36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jcin.2012.01.012","article-title":"Successful recanalization of chronic total occlusions is associated with improved long-term survival.","volume":"5","author":"Jones","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"zoi230719r37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jcin.2008.05.004","article-title":"Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel.","volume":"1","author":"Safley","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"zoi230719r38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.amjcard.2015.02.038","article-title":"Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions.","volume":"115","author":"Christakopoulos","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"zoi230719r39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12471-020-01503-0","article-title":"Percutaneous coronary intervention versus medical therapy for chronic total coronary occlusions: a systematic review and meta-analysis of randomised trials.","volume":"29","author":"van Veelen","year":"2021","journal-title":"Neth Heart J"},{"issue":"1","key":"zoi230719r40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12471-020-01470-6","article-title":"Coronary physiology before and after chronic total occlusion treatment: what does it tell us?","volume":"29","author":"Keulards","year":"2021","journal-title":"Neth Heart J"},{"issue":"11","key":"zoi230719r41","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.4244\/EIJ-D-22-00118","article-title":"Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention.","volume":"18","author":"Keulards","year":"2022","journal-title":"EuroIntervention"},{"issue":"1","key":"zoi230719r42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jacc.2005.11.093","article-title":"Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance.","volume":"48","author":"Werner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"zoi230719r28","first-page":"HSI-S11093","article-title":"Article commentary: patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs).","volume-title":"Heal Serv Insights","author":"Weldring","year":"2013"},{"key":"zoi230719r29","unstructured":"World Health Organization. The Global Health Observatory: health and well-being. Accessed June 13, 2023. https:\/\/www.who.int\/data\/gho\/data\/major-themes\/health-and-well-being"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2807447\/kucukseymen_2023_oi_230719_1689189284.14046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T11:41:32Z","timestamp":1689853292000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2807447"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.24522","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}